Contact:Bob Harris

Even when she was in the State Senate, Kay Hagan had a lucrative investment portfolio that got the benefit of taxpayer money.

In 2008, she filed a report with the US Senate when she was running for her seat in Washington. Her report showed investments in high risk, high reward biotech start up companies that had been funded by the North Carolina Biotechnology Center, a taxpayer funded agency.

At least 3 Hagan companies, Piedmont Pharmaceuticals ,Aldagen and Kucera Pharmaceuticals, received taxpayer funding from the center. State Senator Hagan voted to fund the center


Yes, Senator Hagan knows how to make money for herself.

Your comment will be posted after it is approved.

Leave a Reply.